These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6434893

  • 21. OKY-1581, a potential selective thromboxane synthetase inhibitor.
    Feuerstein N, Ramwell PW.
    Eur J Pharmacol; 1981 Feb 19; 69(4):533-4. PubMed ID: 7195815
    [No Abstract] [Full Text] [Related]

  • 22. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J, Mehta P, Ostrowski N.
    Prostaglandins Leukot Med; 1983 Sep 19; 12(1):49-52. PubMed ID: 6356153
    [Abstract] [Full Text] [Related]

  • 23. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium.
    McCluskey ER, Kramer JB, Corr PB, Needleman P.
    Biochem Biophys Res Commun; 1984 Jun 15; 121(2):552-7. PubMed ID: 6539597
    [Abstract] [Full Text] [Related]

  • 24. Sudden death induced by intracoronary platelet aggregation.
    Yamazaki H, Isohisa I, Tanoue K.
    Jpn Circ J; 1983 May 15; 47(5):596-607. PubMed ID: 6406715
    [Abstract] [Full Text] [Related]

  • 25. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ, Underwood DC, Cowen KH, Wegmann MJ, Graybar GB, Hyman AL, McNamara DB, Kadowitz PJ.
    J Appl Physiol (1985); 1987 May 15; 62(5):2066-74. PubMed ID: 2954941
    [Abstract] [Full Text] [Related]

  • 26. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P, Matintalo M, Dahl ML.
    Prostaglandins Leukot Med; 1983 Nov 15; 12(3):299-303. PubMed ID: 6419237
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T, Ogawa K, Sakai K, Watanabe J, Satake T, Kayama N, Hiraku S, Naito J.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Nov 15; 11():245-51. PubMed ID: 6221531
    [No Abstract] [Full Text] [Related]

  • 29. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on the action of bronchoactive agents in guinea pig tracheal strips and on arachidonate metabolism in guinea pig lung lobes.
    Kitamura S, Ishihara Y, Takaku F.
    Prostaglandins Leukot Med; 1984 Jun 15; 14(3):341-50. PubMed ID: 6431447
    [Abstract] [Full Text] [Related]

  • 30. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
    Kitamura S, Ishihara Y, Takaku F.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan 15; 22(1):3-8. PubMed ID: 6539836
    [No Abstract] [Full Text] [Related]

  • 31. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions].
    Kikuchi S, Takehana Y, Hamano S, Ichikawa K, Komatsu H, Okegawa T, Ikeda S.
    Nihon Yakurigaku Zasshi; 1990 Mar 15; 95(3):131-7. PubMed ID: 2141317
    [Abstract] [Full Text] [Related]

  • 32. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ, Driscoll EM, Romson JL, Pitt B, Lucchesi BR.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):285-91. PubMed ID: 6542526
    [Abstract] [Full Text] [Related]

  • 33. OKY-046 inhibits thromboxane synthesis with no effect on brain edema and neurological status in head traumatized rats.
    Shapira Y, Yadid G, Cotev S, Shohami E.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr 15; 36(1):49-55. PubMed ID: 2740414
    [Abstract] [Full Text] [Related]

  • 34. The effects of drugs on the arachidonate cascade in experimentally burned rabbits.
    Ono I, Ohura T, Azami K, Ogino H, Sasaki S, Murazumi M.
    J Burn Care Rehabil; 1989 Apr 15; 10(4):314-20. PubMed ID: 2507549
    [Abstract] [Full Text] [Related]

  • 35. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ.
    Br J Clin Pharmacol; 1983 Apr 15; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [Abstract] [Full Text] [Related]

  • 36. Protective actions of a new potent thromboxane receptor antagonist in arachidonate induced sudden death.
    Liao P, Johnson G, Siegfried M, Lefer AM.
    Eicosanoids; 1989 Apr 15; 2(1):33-7. PubMed ID: 2534470
    [Abstract] [Full Text] [Related]

  • 37. Rabbit nephrotoxic nephritis: effect of a thromboxane synthetase inhibitor on evolution and prostaglandin excretion.
    Shinkai Y, Cameron JS.
    Nephron; 1987 Apr 15; 47(3):211-9. PubMed ID: 3317092
    [Abstract] [Full Text] [Related]

  • 38. Selective thromboxane A2 synthetase inhibition in vasospastic angina pectoris.
    Yui Y, Hattori R, Takatsu Y, Kawai C.
    J Am Coll Cardiol; 1986 Jan 15; 7(1):25-9. PubMed ID: 3941213
    [Abstract] [Full Text] [Related]

  • 39. Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock.
    Fukumoto S, Tanaka K.
    Prostaglandins Leukot Med; 1983 Jun 15; 11(2):179-88. PubMed ID: 6576388
    [Abstract] [Full Text] [Related]

  • 40. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
    Chiabrando C, Castagnoli MN, Noseda A, Fanelli R, Rajtar G, Cerletti C, de Gaetano G.
    Prostaglandins Leukot Med; 1984 Oct 15; 16(1):79-88. PubMed ID: 6440153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.